featured
Risk Factors Associated With Hyperglycemia in Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Predicting Hyperglycemia Among Patients Receiving Alpelisib Plus Fulvestrant for Metastatic Breast Cancer
Oncologist 2023 Mar 21;[EPub Ahead of Print], X Ge, CE Behrendt, SE Yost, N Patel, R Samoa, D Stewart, M Sedrak, S Lavasani, J Waisman, Y Yuan, J MortimerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.